Multiple Sclerosis Research at St. Michael’s Hospital

MS Centre

The goal of the new MS centre is to stop the disease and provide the best clinical care and outstanding research. Being the largest MS centre in the country, we have a large concentration of patients that facilitates clinical drug trials in this population.

Theme Lead

Dr. Xavier Montalban

Dr. Montalban has held diverse leadership positions and is currently a Professor of Medicine and Director of the Neurology Department at the University of Toronto. He has contributed more than 500 publications and several book chapters to the academic arena, served on multiple steering committees of clinical trials related to multiple sclerosis, and is a valued member of the International Panel on Multiple Sclerosis Diagnostic Criteria and Clinical Trials. With more than 25 years of research, Dr. Montalban continues to strive to discover more effective therapies for patients with MS and has brought paradigm shifts to the way we understand and treat MS.

Areas of research St. Michael’s MS scientists are investigating include:

  • Clinical trials of different putative MS treatments including a monoclonal antibody to CD20, CD52 as well as teriflunomide and fingolimod
  • Novel MS therapies
  • Development of MS treatment guidelines

MS Projects

coming soon